Mayo Clinic Talks Inflammatory Bowel Disease Series: Diagnosing Inflammatory Bowel Disease (IBD) and Monitoring Modalities
10 snips
Jul 1, 2025 In this engaging discussion, Dr. David H. Bruining and Dr. Nayantara Coelho-Prabhu, both specialists in gastroenterology at the Mayo Clinic, delve into the complexities of diagnosing inflammatory bowel disease (IBD). They highlight the challenges of early detection and the need for a tailored, patient-specific approach. The conversation also covers the innovative 'treat to target' strategy in IBD management, the significance of risk stratification, and the importance of personalized monitoring plans to minimize complications.
AI Snips
Chapters
Transcript
Episode notes
Spotting IBD Early Signs
- Look for a new, acute change in bowel habits, such as multiple daily stools with urgency or nocturnal bowel movements.
- Consider age ranges 16-26 and 55-65 plus systemic signs like iron deficiency anemia when suspecting IBD.
Diagnostic Approach for IBD
- Start IBD diagnosis with bloodwork: CBC, CRP, ESR, liver enzymes, and stool tests including fecal calprotectin.
- Use colonoscopy with terminal ileum evaluation as gold standard; consider CT/MR enterography to assess small bowel involvement.
Symptoms Don’t Equal Disease Activity
- Symptoms often do not correlate with disease activity, especially in Crohn's disease.
- Use objective tools like CRP, fecal calprotectin, imaging, and endoscopy to accurately monitor disease.